- Home
- PACB vs CADL Comparison
PACB vs CADL Comparison
Compare PACB & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PACB
- CADL
- Stock Information
- Founded
- PACB 2000
- CADL 1999
- Country
- PACB United States
- CADL United States
- Employees
- PACB N/A
- CADL N/A
- Industry
- PACB Biotechnology: Laboratory Analytical Instruments
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- PACB Industrials
- CADL Health Care
- Exchange
- PACB Nasdaq
- CADL Nasdaq
- Market Cap
- PACB 364.2M
- CADL 306.4M
- IPO Year
- PACB 2010
- CADL 2021
- Fundamental
- Price
- PACB $1.31
- CADL $8.01
- Analyst Decision
- PACB Buy
- CADL Strong Buy
- Analyst Count
- PACB 13
- CADL 4
- Target Price
- PACB $2.79
- CADL $21.00
- AVG Volume (30 Days)
- PACB 14.1M
- CADL 1.3M
- Earning Date
- PACB 02-13-2025
- CADL 03-27-2025
- Dividend Yield
- PACB N/A
- CADL N/A
- EPS Growth
- PACB N/A
- CADL N/A
- EPS
- PACB N/A
- CADL N/A
- Revenue
- PACB $154,014,000.00
- CADL N/A
- Revenue This Year
- PACB $7.12
- CADL N/A
- Revenue Next Year
- PACB $26.83
- CADL N/A
- P/E Ratio
- PACB N/A
- CADL N/A
- Revenue Growth
- PACB N/A
- CADL N/A
- 52 Week Low
- PACB $1.16
- CADL $1.34
- 52 Week High
- PACB $4.42
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- PACB 40.33
- CADL 46.12
- Support Level
- PACB $1.27
- CADL $7.30
- Resistance Level
- PACB $1.47
- CADL $8.61
- Average True Range (ATR)
- PACB 0.15
- CADL 1.12
- MACD
- PACB -0.01
- CADL -0.21
- Stochastic Oscillator
- PACB 6.78
- CADL 11.13
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.